Omega-3 PUFA: good or bad for prostate cancer?
The objective of this meta-analysis was to estimate quantitatively the associations between intake or status of omega-3 polyunsaturated (omega-3 PUFA) fatty acids and occurrence of prostate cancer in observational studies in humans. We combined risk estimates across studies using random-effects models. The combined estimate showed an increased risk of prostate cancer in men with a high intake or blood level of alpha-linolenic acid (ALA) (combined relative risk (RR) 1.36; 95% CI 1.08-1.70). The association is stronger in the case-control studies (RR 1.84; 95% CI 1.04-3.25) than in the prospective studies (RR 1.10; 0.91-1.32). Ecosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not significantly associated with prostate cancer. The association between high intake of ALA and prostate cancer is of concern and needs further study. However, the fact that the prospective studies do not show a clear association makes a true effect of intake of ALA on prostate cancer less likely.